The answer depends on what kind of milk and what kind of cancer. A large pan-cancer analysis found that whole milk and reduced-fat (2%) milk after a cancer diagnosis were linked to higher death rates, while skim milk was associated with modestly lower mortality from both cancer and all causes. That split runs through nearly all the research on this topic: dairy fat, rather than dairy itself, appears to be the pivotal variable. But cancer type matters too, because dairy consistently looks protective against colorectal cancer while raising concerns in prostate cancer and some hormone-driven tumors.
The Fat Content Split
A 2025 prospective analysis tracking thousands of cancer survivors over a median of more than 13 years found strikingly different outcomes depending on which milk people drank after diagnosis. Each additional roughly 200-gram daily serving of whole milk was linked to about a 10 percent increase in all-cause mortality. Two-percent milk showed a similar pattern, with a 6 percent bump in all-cause mortality and a 7 percent increase in cancer-specific mortality. Skim milk went the other direction: it was associated with a 5 percent reduction in all-cause mortality and a 6 percent reduction in cancer mortality. The researchers estimated that substituting whole or 2% milk with skim or 1% milk could translate to roughly two additional life-years when the swap begins around age 55.
1PubMed. Prospective pan-cancer analysis of postdiagnosis milk and yogurt intake types with mortality and life expectancyThis pattern is not unique to that one study. A separate analysis in breast cancer survivors found that low-fat dairy intake was unrelated to recurrence or survival, while high-fat dairy told a different story: women consuming one or more servings of high-fat dairy products per day had roughly 49 percent higher breast cancer mortality compared with those who ate little or none. The higher risk was consistent across different types of high-fat dairy, including whole milk, cream, cheese, and ice cream.
2PubMed Central. High- and Low-Fat Dairy Intake, Recurrence, and Mortality After Breast Cancer DiagnosisThe practical takeaway here is blunt: lumping all dairy together in a yes-or-no answer about cancer is misleading. A glass of skim milk and a glass of whole milk are not interchangeable from a cancer-outcomes perspective. Most of the fear around dairy and cancer is really fear around dairy fat, and the evidence suggests that fear is not unfounded.
Colorectal Cancer, Where Dairy Looks Protective
If there is one cancer type where milk gets a genuinely positive report card, it is colorectal cancer. A systematic review and meta-analysis of cohort studies found that higher consumption of total dairy products was associated with about a 20 percent lower risk of colorectal cancer, and total milk specifically with an 18 percent reduction. Low-fat milk appeared especially protective, with a roughly 24 percent reduction in colorectal cancer risk and a 27 percent reduction in colon cancer specifically. Even cheese showed a modest inverse association, with about 15 percent lower risk.
3PubMed Central. Association Between Dairy Product Consumption and Colorectal Cancer Risk in Adults: A Systematic Review and Meta-Analysis of Epidemiologic StudiesA large UK study using both observational and genetic evidence concluded that dairy products help protect against colorectal, colon, and rectal cancers, and that this protection is driven largely or wholly by calcium.
4Nature Communications. Diet-wide analyses for risk of colorectal cancer: prospective study of 12,251 incident cases among 542,778 women in the UKThe evidence goes beyond prevention. Among people who had already developed colorectal adenomas (precancerous polyps), dairy intake was inversely related to recurrence risk even after accounting for calcium and vitamin D. Milk was the main driver: people in the highest third of milk intake had roughly half the recurrence risk of those in the lowest third.
5PubMed. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrenceCalcium binds to bile acids and free fatty acids in the gut, which can otherwise irritate the colon lining and promote abnormal cell growth. Milk also delivers vitamin D, which plays its own role in regulating cell division. For people who have had or are at risk of colorectal cancer, moderate dairy consumption, especially low-fat milk, appears to be genuinely beneficial rather than harmful.
Prostate Cancer, Where the Evidence Points to Harm
The picture for prostate cancer is essentially the reverse. Multiple epidemiological studies have documented a positive association between milk consumption and both the risk of developing prostate cancer and prostate cancer-specific mortality.
6PubMed Central. Milk Consumption and Prostate Cancer: A Systematic ReviewA study of U.S. male physicians found that men who drank one or more servings of whole milk daily had more than double the risk of progression to fatal prostate cancer compared with men who did not drink whole milk. That association was specific to whole milk; lower-fat varieties did not carry the same risk.
7The American Journal of Clinical Nutrition. Whole Milk Intake is Associated with Prostate Cancer-Specific Mortality among U.S. Male PhysiciansAnother study looked at dairy intake after a prostate cancer diagnosis. Men consuming three or more servings per day of total dairy products had 76 percent higher total mortality and a substantially elevated risk of prostate cancer-specific mortality compared with men consuming less than one serving per day. The association with high-fat dairy appeared stronger, although the difference between high-fat and low-fat dairy did not reach statistical significance in this particular study.
8PubMed Central. Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortalityFor men living with prostate cancer, the research consistently suggests that heavy dairy consumption, especially whole milk, is associated with worse outcomes. Whether moderate amounts of low-fat dairy carry meaningful risk remains unclear, but the signal from whole milk is strong enough that many oncology nutritionists recommend prostate cancer patients limit full-fat dairy.
Breast Cancer and Hormonal Concerns
Breast cancer sits in a complicated middle ground. As noted, the research on breast cancer survivors shows that high-fat dairy raises mortality risk while low-fat dairy appears neutral. But there is a separate layer of concern around hormones in commercial milk. Cow’s milk, which typically comes from pregnant cows, contains measurable amounts of bovine estrogens and progesterone that are biologically active in humans.
9PubMed Central. Consumption of Cow’s Milk and Possible Risk of Breast CancerWhether those hormones meaningfully influence hormone-receptor-positive breast tumors is still an open question. The epidemiological evidence linking dairy consumption to breast cancer development remains inconclusive, with studies pointing in different directions depending on the population, the type of dairy, and the follow-up period. What the data do show more clearly is the post-diagnosis picture: for women who already have breast cancer, high-fat dairy is associated with worse survival, and the risk appears to hold across multiple types of full-fat products.
2PubMed Central. High- and Low-Fat Dairy Intake, Recurrence, and Mortality After Breast Cancer DiagnosisThe mechanism probably involves more than hormones alone. Dairy fat is also a vehicle for fat-soluble contaminants, including pesticide residues that accumulate in the fat fraction and have carcinogenic potential.
10The American Journal of Clinical Nutrition. Consumption of dairy products and the risk of breast cancer: a review of the literatureIGF-1 and Why Growth Factors Matter
One of the central biological concerns about milk and cancer involves insulin-like growth factor 1, or IGF-1. Milk and dairy products are naturally rich in this protein, and drinking milk is known to raise circulating IGF-1 levels.
11PubMed Central. Effects of IGF1 rs6214 Polymorphism and Milk Consumption on Serum Levels of IGF-1 and GH and Body CompositionIGF-1 promotes cell growth and inhibits programmed cell death, which is exactly what healthy tissues need during childhood and wound healing but is unhelpful when cancerous cells are present. Higher circulating IGF-1 has been associated with increased risk of several cancers, and dairy products may also contain pesticides and other contaminants that have their own carcinogenic potential, particularly in the fat fraction.
10The American Journal of Clinical Nutrition. Consumption of dairy products and the risk of breast cancer: a review of the literatureAt the same time, milk fat contains compounds that work in the opposite direction. Conjugated linoleic acid (CLA), sphingomyelin, butyric acid, and certain vitamins all show anticarcinogenic activity in laboratory and animal models. In rats, as little as 0.1 percent dietary CLA inhibited mammary tumor development regardless of how much fat was in the overall diet.
12Journal of Dairy Science. Cows’ milk fat components as potential anticarcinogenic agentsThis is part of why the research on dairy and cancer can seem contradictory: milk simultaneously delivers growth-promoting signals like IGF-1 and growth-inhibiting compounds like CLA. Which effect dominates likely depends on the cancer type, the fat content of the dairy, and the individual’s own biology. For colorectal cancer, calcium and other protective factors seem to win. For prostate cancer and high-fat dairy in breast cancer, the growth-promoting side appears to dominate.
Whey Protein and the Muscle-Wasting Problem
One area where dairy components have clear value for cancer patients is in fighting muscle loss. Cancer-related muscle wasting, or cachexia, affects a large proportion of patients with advanced disease and is independently linked to worse treatment outcomes and survival. Maintaining muscle mass and strength during treatment is a real clinical priority, not just a quality-of-life concern.
A scoping review of protein supplementation in cancer patients found that energy and protein delivered through oral nutritional supplements, enteral feeding, or parenteral nutrition had a more robust effect on preserving muscle mass and strength than isolated protein or amino acid supplements alone.
13PubMed Central. The Impact of Protein Supplementation Targeted at Improving Muscle Mass on Strength in Cancer Patients: A Scoping ReviewWhey protein, derived from milk, is one of the highest-quality protein sources available and is widely used in cancer nutrition support. Emerging research on a soy-whey dual-protein blend showed that it could reduce muscle protein breakdown in an animal model of lung cancer cachexia while also lowering systemic inflammation and protecting the liver, kidneys, and heart from chemotherapy-related damage, all without interfering with the antitumor effects of the chemotherapy drug.
14Food and Humanity. Soy-whey dual-protein alleviates muscle atrophy in lung cancer cachexia by regulating the FoxO/MuRF-1/Atrogin-1 signaling pathwayA review of dietary factors in oncology immunotherapy went further, noting that dairy proteins, including both the casein and whey fractions, have demonstrated anticancer effects in experimental settings. Beta-lactoglobulin, the main component of whey, has antioxidant and immune-stimulating properties.
15Nature Publishing Group. Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive reviewFor a patient who is losing weight and struggling to eat enough, a glass of skim milk or a whey protein shake provides high-quality protein with minimal dairy fat. That is a very different proposition from drinking whole milk, and the risk-benefit math tilts strongly in favor of dairy-derived protein supplements for patients dealing with cachexia or treatment-related weight loss.
Fermented Dairy and the Gut Microbiome
Yogurt and other fermented dairy products occupy their own niche in this conversation. The gut microbiome has become a major focus in cancer treatment because the composition of intestinal bacteria can influence how well patients respond to immunotherapy. Patients with diverse, healthy gut flora tend to respond better to checkpoint inhibitors, the class of drugs that has transformed treatment for melanoma, lung cancer, and other tumor types.
A review in the European Journal of Cancer concluded that fermented foods may have a beneficial effect on the gut microbiome and should be introduced where possible in cancer patients’ diets.
16PubMed. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implicationsYogurt delivers live bacterial cultures that can contribute to microbial diversity while also providing the protein, calcium, and other nutrients found in milk. For patients receiving immunotherapy, incorporating fermented dairy may carry benefits beyond basic nutrition. That said, the research in this area is still early, and no clinical trial has yet shown that yogurt intake directly improves immunotherapy response rates in humans. The recommendation is based on plausible mechanisms and the general observation that microbial diversity supports treatment response.
When Treatment Makes Milk Harder to Digest
Even if a cancer patient wants to drink milk, their treatment may get in the way. Chemotherapy can damage the lining of the small intestine, where lactase, the enzyme needed to digest milk sugar, is produced. A study of 27 patients undergoing chemotherapy found that about 30 percent developed laboratory evidence of lactose malabsorption after treatment, though only about 11 percent experienced actual clinical symptoms like bloating, gas, or diarrhea.
17PubMed. Chemotherapy-induced lactose intolerance in adultsPelvic radiation can cause similar problems. A study of patients undergoing radical pelvic radiotherapy found that about 15 percent developed lactose intolerance during treatment, with some experiencing worsened bowel frequency or fecal incontinence.
18PubMed. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational studyThis treatment-induced lactose intolerance is usually temporary. Once the gut lining heals after treatment ends, most people regain their ability to digest lactose. In the meantime, lactose-free milk provides the same nutritional profile without the digestive misery, and fermented dairy products like yogurt and aged cheese contain much less lactose than fresh milk. Patients dealing with mucositis, the painful mouth and throat inflammation caused by some chemotherapy regimens, may also find milk soothing. An animal study found that a whey-derived growth factor extract applied to the oral lining significantly reduced chemotherapy-induced mouth ulcers in a dose-dependent manner.
19PubMed. Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamsterPlant-Based Milk Alternatives
For patients who want to avoid dairy entirely, whether because of lactose intolerance, a hormone-sensitive cancer, or personal preference, plant-based milks are an option, but they come with trade-offs. Soy milk is the closest to cow’s milk in protein content and has its own body of research suggesting potential anticancer benefits. Oat, almond, and rice milks are much lower in protein and often need to be fortified with calcium and vitamin D to match dairy’s nutritional contribution.
A review comparing dairy and plant-based milks found that recent meta-analyses do not support a strong link between moderate dairy intake and cancer or all-cause mortality overall. Healthy plant-based diets, however, are associated with lower risk of diabetes, cardiovascular disease, some cancers, and healthier body weight.
20PubMed Central. Dairy and Plant-Based Milks: Implications for Nutrition and Planetary HealthThe key word is “moderate.” The evidence against dairy in cancer comes predominantly from high-fat dairy and from heavy consumption. A patient who switches entirely to plant-based alternatives needs to be intentional about getting enough protein, calcium, and vitamin D from other sources, especially if they are already battling weight loss or cachexia. For patients with prostate cancer or hormone-sensitive breast cancer, plant-based milks may represent a reasonable swap, particularly if they are fortified and paired with adequate protein from other foods.
Bioactive Compounds That Complicate the Picture
Part of the reason the dairy-and-cancer question resists a clean answer is that milk is not a single substance. It is a complex fluid containing hundreds of bioactive compounds, some of which promote growth and some of which suppress it. The same glass of whole milk delivers calcium that may protect the colon, IGF-1 that may promote tumor growth, CLA that inhibits cancer cells in lab settings, estrogens from the dairy cow, high-quality whey protein that supports immune function, and saturated fat that concentrates fat-soluble contaminants.
Researchers have gone back and forth on how to weigh these competing effects for decades, and the honest answer is that the net result depends on context. A 70-year-old man managing early-stage prostate cancer and a 45-year-old woman in remission from colon cancer are asking the same question but should get very different guidance. The evidence is clear enough to make a few confident statements: whole milk is consistently associated with worse cancer outcomes, skim milk appears neutral or modestly beneficial, dairy is protective against colorectal cancer specifically, and whey protein is a valuable nutritional tool during treatment. Outside of those anchors, individual risk factors, cancer type, and treatment stage all shape whether a glass of milk is a sensible choice or one worth rethinking.